Starling Oncology Executive and Leadership Team

November, 2026

Leadership Overview

Starling Oncology has 7 executives leading key functions including strategy, financial oversight, operational scaling, clinical excellence, regional market expansion, and administrative governance.

Committed to transforming cancer care delivery, Starling Oncology advances value-based treatment models to improve patient outcomes across diverse communities through integrated, evidence-based oncology services.

Leadership Roles at Starling Oncology

  • Chief Executive Officer - Paul Johnson
  • Chief Financial Officer - Robert Carter
  • Chief Operating Officer - Daniel Virnich
  • Regional President - Dan Ayer
  • Regional President - Stacy Constantine
  • Chief Medical Officer - Yale Podnos
  • Chief Administrative Officer (CAO) - Kristin England
  • Paul Johnson - Chief Executive Officer

    Paul Johnson, the Chief Executive Officer at Starling Oncology, directs the overarching strategic vision for the organization. Johnson architects the long-term growth trajectory by aligning clinical service delivery with value-based care mandates. By fostering partnerships with healthcare providers, the Chief Executive Officer ensures the network maintains high standards for evidence-based oncology treatments. This leadership role involves constant evaluation of market trends to optimize the integrated cancer care delivery model. Paul Johnson maintains focus on expanding the reach of clinical trials and transfusion services to underserved populations. Through rigorous oversight of organizational performance, the Chief Executive Officer drives sustainable improvements in patient care quality. The executive team relies on Johnson to navigate complex regulatory environments while maintaining the core mission of accessible, high-quality cancer treatment. Ultimately, the Chief Executive Officer secures the financial and operational health of the entire enterprise.

    Robert Carter - Chief Financial Officer

    Robert Carter, the Chief Financial Officer at Starling Oncology, manages the fiscal health and capital allocation strategies for the company. Carter oversees the financial planning and analysis required to support the expansion of the clinic network. By monitoring revenue cycles and cost structures, the Chief Financial Officer ensures the viability of value-based care initiatives. This role involves collaborating with clinical leadership to balance resource investment with patient care requirements. Robert Carter directs the financial reporting processes to maintain transparency with stakeholders and regulatory bodies. Through meticulous budget management, the Chief Financial Officer supports the scaling of transfusion services and clinical trial infrastructure. The financial strategy developed by Carter enables the organization to sustain its integrated delivery model across multiple regions. By optimizing capital efficiency, the Chief Financial Officer provides the necessary foundation for long-term growth and operational stability within the competitive oncology sector.
    Robert Carter

    Daniel Virnich - Chief Operating Officer

    Daniel Virnich, the Chief Operating Officer at Starling Oncology, executes the daily operational workflows across the entire network of cancer care clinics. Virnich optimizes the delivery of evidence-based treatments by streamlining patient care coordination and clinical throughput. Overseeing the integration of new facilities, the Chief Operating Officer ensures consistent service quality across all geographic locations. This leadership role involves managing the logistical complexities of transfusion services and clinical trial administration. Daniel Virnich drives operational efficiency by implementing standardized protocols that enhance the patient experience. By coordinating with regional leadership, the Chief Operating Officer maintains alignment between clinical performance and corporate objectives. The operational framework established by Virnich supports the company's mission to provide accessible, high-value oncology care. Through continuous process improvement, the Chief Operating Officer mitigates operational risks and fosters a culture of excellence in every clinic within the network.
    Daniel Virnich

    Dan Ayer - Regional President

    Dan Ayer, the Regional President at Starling Oncology, manages the operational performance and market growth within assigned territories. Ayer directs the expansion of the clinic network by identifying opportunities to increase access to oncology services. Overseeing regional teams, the Regional President ensures that local operations align with the company's value-based care mission. This role involves building relationships with local healthcare providers and community stakeholders to strengthen the integrated care delivery model. Dan Ayer monitors regional performance metrics to drive efficiency in transfusion services and clinical trial participation. By addressing local market challenges, the Regional President supports the overall strategic goals of the organization. The leadership provided by Ayer facilitates the successful implementation of corporate initiatives at the community level. Through proactive management of regional resources, the Regional President secures a strong market presence and ensures consistent delivery of high-quality cancer care across the assigned geographic footprint.

    Stacy Constantine - Regional President

    Stacy Constantine, the Regional President at Starling Oncology, oversees the strategic execution of oncology services within specific regional markets. Constantine directs the operational scaling of clinics to ensure that patients receive timely, evidence-based care. By managing regional clinical staff and administrative teams, the Regional President fosters a collaborative environment focused on patient outcomes. This role involves optimizing the delivery of transfusions and clinical trials to meet the unique needs of the local population. Stacy Constantine coordinates with the executive leadership to implement value-based care strategies that enhance service accessibility. Through the analysis of regional data, the Regional President identifies areas for process improvement and service expansion. The leadership provided by Constantine ensures that the company maintains a competitive edge while upholding high standards of medical care. By driving regional growth, the Regional President contributes significantly to the overall success and mission of the organization.

    Yale Podnos - Chief Medical Officer

    Yale Podnos, the Chief Medical Officer at Starling Oncology, leads the clinical strategy and ensures the highest standards of evidence-based oncology care. Podnos directs the medical staff and oversees the implementation of advanced treatment protocols across the clinic network. By supervising clinical trials and patient care initiatives, the Chief Medical Officer maintains the organization's commitment to medical excellence. This role involves collaborating with the executive team to integrate new therapeutic advancements into the value-based care model. Yale Podnos monitors clinical outcomes to ensure that patient care remains effective and compassionate. Through the development of rigorous medical standards, the Chief Medical Officer supports the professional growth of affiliated providers. The clinical leadership provided by Podnos ensures that the company remains at the forefront of oncology services. By championing patient-centered care, the Chief Medical Officer directly influences the quality and safety of treatments delivered to communities.
    Yale Podnos

    Kristin England - Chief Administrative Officer (CAO)

    Kristin England, the Chief Administrative Officer (CAO) at Starling Oncology, directs the internal infrastructure and administrative functions that support the company's clinical mission. England oversees human resources, organizational development, and corporate compliance to ensure a stable operational environment. By streamlining administrative processes, the Chief Administrative Officer (CAO) enables clinical teams to focus entirely on patient care and treatment delivery. This role involves managing the organizational culture and ensuring that all administrative policies align with value-based care objectives. Kristin England coordinates with other C-suite leaders to implement systems that improve efficiency and communication across the network. Through the oversight of corporate governance, the Chief Administrative Officer (CAO) mitigates risk and supports the long-term sustainability of the business. The leadership provided by England ensures that the company possesses the necessary administrative foundation to scale its oncology services effectively while maintaining high standards of operational integrity.
    Kristin England

    Explore Leadership Teams in Hospitals & Physicians Clinics

    Frequently Asked Questions Regarding Starling Oncology Top Executives and Leadership Team

    Who leads Starling Oncology?
    Starling Oncology is led by Paul Johnson (Chief Executive Officer), along with executives such as Robert Carter (Chief Financial Officer) and Daniel Virnich (Chief Operating Officer).
    Who is part of Starling Oncology’s executive team?
    The executive team of Starling Oncology includes leaders such as Paul Johnson (Chief Executive Officer), Robert Carter (Chief Financial Officer), Daniel Virnich (Chief Operating Officer) and other senior executives.
    How many executives does Starling Oncology have?
    Starling Oncology has 7 executives leading key business areas.
    What roles are included in Starling Oncology’s leadership team?
    The leadership team of Starling Oncology includes roles such as Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Regional President, Regional President.